Cynosure Group LLC cut its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 54.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 893 shares of the biotechnology company's stock after selling 1,062 shares during the quarter. Cynosure Group LLC's holdings in Axon Enterprise were worth $531,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also added to or reduced their stakes in AXON. Massachusetts Financial Services Co. MA raised its position in shares of Axon Enterprise by 82.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 551,197 shares of the biotechnology company's stock valued at $327,587,000 after purchasing an additional 249,513 shares in the last quarter. Groupama Asset Managment boosted its stake in Axon Enterprise by 0.3% during the 4th quarter. Groupama Asset Managment now owns 501,260 shares of the biotechnology company's stock valued at $297,909,000 after acquiring an additional 1,260 shares during the last quarter. OV Management LLC grew its holdings in Axon Enterprise by 6.0% during the 4th quarter. OV Management LLC now owns 3,713 shares of the biotechnology company's stock worth $2,207,000 after acquiring an additional 209 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth about $3,931,000. Finally, Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 3.7% in the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after purchasing an additional 65,097 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Axon Enterprise
In other news, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 6.10% of the company's stock.
Axon Enterprise Price Performance
AXON traded up $28.72 on Tuesday, reaching $531.27. The company had a trading volume of 260,479 shares, compared to its average volume of 807,466. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a market capitalization of $40.71 billion, a P/E ratio of 137.28, a PEG ratio of 5.17 and a beta of 1.13. The company has a fifty day moving average of $580.21 and a 200-day moving average of $556.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.
Analyst Ratings Changes
Several research firms recently issued reports on AXON. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Needham & Company LLC reiterated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $604.67.
Check Out Our Latest Report on Axon Enterprise
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
